INJ Up 15% Weekly — Short-Term Bounce Tests Key $7.65–$9 Resistance

Published: 2025-11-28 11:58:05 |

Injective (INJ) has rallied roughly 15% over the past week, appearing as a potential early reversal after a larger downtrend. Price currently trades between about $4 and $6.50, with immediate support near $4.03. Key resistance levels to watch are $7.65 and $9.45 (previous analysis also referenced $8 and $16 levels but the most recent data centers on $7.65–$9.45). The one-week gain exceeds 5% while monthly performance remains down ~25% and the token sits roughly 50% below its level six months ago. Technical momentum indicators — notably an RSI above 60 — point to upside potential toward the $7–$9 range (an approximate 20–40% gain from current levels) if upward momentum is sustained. Traders should monitor volume and whether major market leaders (BTC, ETH, BNB) confirm strength; without rising volume or broad-market support, the move may be a short-term bounce rather than a durable trend reversal. Watch for a clean break and follow-through above $7.65 with improving volume as a tactical entry signal; failure to hold the $4 support would warn of renewed downside risk.

Neutral

The combined coverage signals a short-term bullish momentum for INJ but not a confirmed long-term reversal. Positive factors: a 15% weekly rally, RSI above 60, and clearly defined upside targets near $7–$9 that imply 20–40% potential gains from current levels. Negative/neutral factors: INJ remains down ~25% month-to-date and ~50% versus six months ago, earlier reports cited higher resistance levels which remain unmet, and the rally lacks confirmed volume and broader-market confirmation. For traders, this translates to a tactical opportunity: a measured long bias if price breaks $7.65 with rising volume and market support; otherwise the move should be treated as a bounce with tight risk management (watch $4 support). Therefore the expected immediate price impact is mixed — possible short-term upside if confirmation occurs, but insufficient to label the outlook outright bullish without follow-through.